Exelixis Inc - Company Profile

Powered by

All the sales intelligence you need on Exelixis Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Exelixis Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Exelixis Inc.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Exelixis Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Exelixis Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Stelios Papadopoulos, Ph.D.

Chairman Executive Board Since: 1994 Age: 77

Dr. Stelios Papadopoulos has been the Chairman of the company since 1994. Prior to this, he served as the Vice Chairman of Cowen & Co LLC since 2006. Previously, he served as the Chairman of PaineWebber Development Corp. Prior to this, he served as the Vice President in the Equity Research Department at Drexel Burnham Lambert.

Read Hide full bio of Stelios Papadopoulos, Ph.D.

Michael M. Morrissey, Ph.D.

Director; President; Chief Executive Officer Executive Board Since: 2010 Age: 65

Dr. Michael M. Morrissey has been the President, Chief Executive Officer, and Director of the company since 2010. Prior to this, he served as the President of Research and Development from 2007 to 2010 of the company. Previously, he served as the Executive Vice President, Discovery in 2006; Senior Vice President, Discovery from 2003 to 2005 and Vice President of Discovery Research from 2000 to 2002. Dr. Morrissey also served at Berlex Biosciences as the Vice President of Discovery Research, Senior Scientist and Project Team Leader in Medicinal Chemistry at CIBA-Geigy Corporation from 1986 to 1991.

Read Hide full bio of Michael M. Morrissey, Ph.D.

Christopher J. Senner

Executive Vice President; Chief Financial Officer Senior Management Since: 2015 Age: 58

Mr. Christopher J. Senner has been the Executive Vice President and Chief Financial Officer of the company since 2015. Prior to this, he served as the Vice President, Corporate Finance at Gilead Sciences in 2010. Previously, he served as the Vice President, Finance and Chief Financial Officer of Wyeth Pharmaceutical's U.S. Region from 2007 to 2009.

Read Hide full bio of Christopher J. Senner

Brenda J. Hefti, J.D., Ph.D.

General Counsel; Senior Vice President Senior Management Age: 52

Patrick J. Haley

Executive Vice President - Commercial Senior Management Since: 2020 Age: 50
Gain a 360-degree view of Exelixis Inc and make more informed decisions for your business Gain a 360-degree view of Exelixis Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer